eCite Digital Repository

Anti-inflammatories in Alzheimer's disease-potential therapy or spurious correlate?

Citation

Rivers-Auty, J and Mather, AE and Peters, R and Lawrence, CB and Brough, D, Alzheimer’s Disease Neuroimaging Initiative, Anti-inflammatories in Alzheimer's disease-potential therapy or spurious correlate?, Brain Communications, 2, (2) pp. 1-14. ISSN 2632-1297 (2020) [Refereed Article]


Preview
PDF
518Kb
  

Copyright Statement

Copyright 2020 the author. Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/

DOI: doi:10.1093/braincomms/fcaa109

Abstract

Epidemiological evidence suggests non-steroidal anti-inflammatory drugs reduce the risk of Alzheimer’s disease. However, clinical trials have found no evidence of non-steroidal anti-inflammatory drug efficacy. This incongruence may be due to the wrong non-steroidal anti-inflammatory drugs being tested in robust clinical trials or the epidemiological findings being caused by confounding factors. Therefore, this study used logistic regression and the innovative approach of negative binomial generalized linear mixed modelling to investigate both prevalence and cognitive decline, respectively, in the Alzheimer’s Disease Neuroimaging dataset for each commonly used non-steroidal anti-inflammatory drug and paracetamol. Use of most non-steroidal anti-inflammatories was associated with reduced Alzheimer’s disease prevalence yet no effect on cognitive decline was observed. Paracetamol had a similar effect on prevalence to these non-steroidal anti-inflammatory drugs suggesting this association is independent of the anti-inflammatory effects and that previous results may be due to spurious associations. Interestingly, diclofenac use was significantly associated with both reduce incidence and slower cognitive decline warranting further research into the potential therapeutic effects of diclofenac in Alzheimer’s disease.

Item Details

Item Type:Refereed Article
Keywords:Alzheimer’s disease, NSAID, anti-inflammatory, inflammation, progression
Research Division:Biomedical and Clinical Sciences
Research Group:Neurosciences
Research Field:Neurology and neuromuscular diseases
Objective Division:Health
Objective Group:Clinical health
Objective Field:Treatment of human diseases and conditions
UTAS Author:Rivers-Auty, J (Dr Jack Auty)
ID Code:143283
Year Published:2020
Deposited By:Medicine
Deposited On:2021-03-10
Last Modified:2021-05-26
Downloads:2 View Download Statistics

Repository Staff Only: item control page